| A systematic review of SARS-CoV-2 vaccine candidates Y Dong*, T Dai*, Y Wei*, L Zhang, M Zheng, F Zhou Signal transduction and targeted therapy 5 (1), 1-14, 2020 | 661 | 2020 |
| Liquid–liquid phase separation in human health and diseases B Wang*, L Zhang*, T Dai*, Z Qin*, H Lu, L Zhang, F Zhou Signal Transduction and Targeted Therapy 6 (1), 1-16, 2021 | 344 | 2021 |
| Targeting liquid–liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity S Wang*, T Dai*, Z Qin*, T Pan*, F Chu, L Lou, L Zhang, B Yang, H Huang, ... Nature Cell Biology 23 (7), 718-732, 2021 | 187 | 2021 |
| Tumor-derived exosomes antagonize innate antiviral immunity L Gao*, L Wang*, T Dai*, K Jin*, Z Zhang*, S Wang, F Xie, P Fang, B Yang, ... Nature immunology 19 (3), 233-245, 2018 | 185 | 2018 |
| YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKKɛ-mediated phosphorylation S Wang, F Xie, F Chu, Z Zhang, B Yang, T Dai, L Gao, L Wang, L Ling, ... Nature immunology 18 (7), 733-743, 2017 | 171 | 2017 |
| The interactions between cGAS-STING pathway and pathogens Z Cheng*, T Dai*, X He*, Z Zhang, F Xie, S Wang, L Zhang, F Zhou Signal transduction and targeted therapy 5 (1), 1-15, 2020 | 155 | 2020 |
| Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions B Wang*, L Zhang*, Y Wang, T Dai, Z Qin, F Zhou, L Zhang Signal Transduction and Targeted Therapy 7 (1), 1-15, 2022 | 120 | 2022 |
| Protein N-myristoylation: functions and mechanisms in control of innate immunity B Wang*, T Dai*, W Sun*, Y Wei*, J Ren, L Zhang, M Zhang, F Zhou Cellular & Molecular Immunology 18 (4), 878-888, 2021 | 64 | 2021 |
| TNF alpha inhibits myogenic differentiation of C2C12 cells through NF-κB activation and impairment of IGF-1 signaling pathway Q Zhao*, ST Yang*, JJ Wang*, J Zhou, SS Xing, CC Shen, XX Wang, ... Biochemical and biophysical research communications 458 (4), 790-795, 2015 | 61 | 2015 |
| The way of SARS-CoV-2 vaccine development: success and challenges Y Dong*, T Dai*, B Wang*, L Zhang*, LH Zeng, J Huang, H Yan, L Zhang, ... Signal transduction and targeted therapy 6 (1), 1-14, 2021 | 55 | 2021 |
| FAF1 regulates antiviral immunity by inhibiting MAVS but is antagonized by phosphorylation upon viral infection T Dai*, L Wu*, S Wang, J Wang, F Xie, Z Zhang, X Fang, J Li, P Fang, F Li, ... Cell Host & Microbe 24 (6), 776-790. e5, 2018 | 45 | 2018 |
| Deactylation by SIRT1 enables liquid–liquid phase separation of IRF3/IRF7 in innate antiviral immunity Z Qin*, X Fang*, W Sun, Z Ma, T Dai, S Wang, Z Zong, H Huang, H Ru, ... Nature Immunology 23 (8), 1193-1207, 2022 | 37 | 2022 |
| Ubiquitin‐specific protease 4 antagonizes osteoblast differentiation through dishevelled F Zhou*, F Li*, P Fang, T Dai, B Yang, H van Dam, J Jia, M Zheng, ... Journal of Bone and Mineral Research 31 (10), 1888-1898, 2016 | 36 | 2016 |
| A dual role of type I interferons in antitumor immunity L Zhou*, Y Zhang*, Y Wang, M Zhang, W Sun, T Dai, A Wang, X Wu, ... Advanced Biosystems 4 (11), 1900237, 2020 | 30 | 2020 |
| Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2 Y Dong*, T Dai*, J Liu*, L Zhang, F Zhou Advanced Science 7 (20), 2001474, 2020 | 17 | 2020 |
| MAVS deSUMOylation by SENP1 inhibits its aggregation and antagonizes IRF3 activation T Dai, L Zhang, Y Ran, M Zhang, B Yang, H Lu, S Lin, L Zhang, F Zhou Nature Structural & Molecular Biology 30 (6), 785-799, 2023 | 15 | 2023 |
| Capturing Protein–Protein Interactions with Acidic Amino Acids Reactive Cross‐Linkers QQ Liao, X Shu, W Sun, H Mandapaka, F Xie, Z Zhang, T Dai, S Wang, ... Small 20 (20), 2308383, 2024 | 1 | 2024 |
| LPA maintains innate antiviral immunity in a pro-active state via STK38L-mediated IRF3 Ser303 phosphorylation S Wang, F Chu, R Xia, J Guan, L Zhou, X Fang, T Dai, F Xie, L Zhang, ... Cell Reports 41 (8), 2022 | 1 | 2022 |
